Drug Database
Back to search

United States· US:33342-177_fa044dee-2fd4-47ad-a675-01eb1a302c48

Pioglitazone and metformin hydrochloride

A metformin and pioglitazone product containing metformin hydrochloride; pioglitazone hydrochloride, registered in United States by Macleods Pharmaceuticals Limited. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD05

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPioglitazone and metformin hydrochlor…ATCA10BD05REGISTER NO.US:33342-177_fa044dee…PACKS LISTED5CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metformin hydrochloride; pioglitazone hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and pioglitazone is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD05 (metformin and pioglitazone), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search metformin and pioglitazone products by name

Metformin and pioglitazone · ATC A10BD05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Manufacturer
Macleods Pharmaceuticals Limited
Country
United States (US)
ATC code
A10BD05
ATC class
Metformin and pioglitazone
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 13, 2026

Packs & prices · 5

  • ndc11
    33342-177-09
  • ndc11
    33342-177-11
  • ndc11
    33342-177-12
  • ndc11
    33342-177-44
  • ndc11
    33342-177-57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and pioglitazone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and pioglitazone against other medicinesHow interaction checks work

Metformin and pioglitazone · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and pioglitazone in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and pioglitazone products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Bulgaria · Пизона Комби
  • Czechia · Novapio Plus
  • Spain · Pioglitazona/Metformina Aristo
  • United Kingdom (Northern Ireland) · Pioglitazone And Metformin Hydrochloride Clydesdale Pharma, Pioglitazone/Metformin Torrent Pharma (Uk)
  • Greece · Pioglitazone/Metformin Genepharm
  • Croatia · Novapio Plus
  • Hungary · Pioglitazone / Metformin Genepharm
  • Iceland · Competact
  • Italy · Pioglitazone E Metformina Docgen, Pioglitazone E Metformina Eg
  • Liechtenstein · Competact
  • Norway · Competact
  • Portugal · Metformina + Pioglitazona Biofarmoz, Metformina + Pioglitazona Farmoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c60d0724-8c18-4d72-99f8-e2f5e4459c92
GET /v1/drugs/c60d0724-8c18-4d72-99f8-e2f5e4459c92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "850; 15",
  "substance": "METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE",
  "productndc": "33342-177",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA204802",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about metformin and pioglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console